1	Genentech	_	NNP	_	_	3	SBJ	_	_
2	Inc.	_	NNP	_	_	1	POSTHON	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	7	NMOD	_	_
5	West	_	NNP	_	_	7	NMOD	_	_
6	German	_	NNP	_	_	7	NMOD	_	_
7	distributor	_	NN	_	_	13	SBJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	its	_	PRP$	_	_	12	NMOD	_	_
10	heart	_	NN	_	_	12	NMOD	_	_
11	drug	_	NN	_	_	12	NMOD	_	_
12	TPA	_	NNP	_	_	8	PMOD	_	_
13	reached	_	VBD	_	_	3	OBJ	_	_
14	a	_	DT	_	_	17	NMOD	_	_
15	joint	_	NN	_	_	17	NMOD	_	_
16	marketing	_	NN	_	_	17	NMOD	_	_
17	agreement	_	NN	_	_	13	OBJ	_	_
18	with	_	IN	_	_	13	ADV	_	_
19	a	_	DT	_	_	20	NMOD	_	_
20	subsidiary	_	NN	_	_	18	PMOD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	Hoechst	_	NNP	_	_	23	NAME	_	_
23	AG	_	NNP	_	_	21	PMOD	_	_
24	,	_	,	_	_	23	P	_	_
25	which	_	WDT	_	_	26	SBJ	_	_
26	makes	_	VBZ	_	_	23	NMOD	_	_
27	the	_	DT	_	_	31	NMOD	_	_
28	rival	_	JJ	_	_	31	NMOD	_	_
29	anti-clotting	_	JJ	_	_	31	NMOD	_	_
30	agent	_	NN	_	_	31	NMOD	_	_
31	streptokinase	_	NNP	_	_	26	OBJ	_	_
32	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	biotechnology	_	NN	_	_	3	NMOD	_	_
3	concern	_	NN	_	_	4	SBJ	_	_
4	said	_	VBD	_	_	0	ROOT	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	agreement	_	NN	_	_	27	SBJ	_	_
7	between	_	IN	_	_	6	NMOD	_	_
8	its	_	PRP$	_	_	12	NMOD	_	_
9	longtime	_	NN	_	_	12	NMOD	_	_
10	West	_	NNP	_	_	12	NMOD	_	_
11	German	_	NNP	_	_	12	NMOD	_	_
12	distributor	_	NN	_	_	7	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	Boehringer-Ingleheim	_	NNP	_	_	20	NMOD	_	_
15	's	_	POS	_	_	14	SUFFIX	_	_
16	Dr.	_	NNP	_	_	20	NMOD	_	_
17	Karl	_	NNP	_	_	20	NMOD	_	_
18	Thomae	_	NNP	_	_	20	NMOD	_	_
19	G.m.b.H.	_	NNP	_	_	20	NMOD	_	_
20	subsidiary	_	NN	_	_	12	APPO	_	_
21	,	_	,	_	_	12	P	_	_
22	and	_	CC	_	_	12	COORD	_	_
23	Hoechst	_	NNP	_	_	26	NMOD	_	_
24	's	_	POS	_	_	23	SUFFIX	_	_
25	Behringwerke	_	NNP	_	_	26	NMOD	_	_
26	subsidiary	_	NN	_	_	22	CONJ	_	_
27	was	_	VBD	_	_	4	OBJ	_	_
28	an	_	DT	_	_	29	NMOD	_	_
29	attempt	_	NN	_	_	27	PRD	_	_
30	to	_	TO	_	_	29	NMOD	_	_
31	expand	_	VB	_	_	30	IM	_	_
32	the	_	DT	_	_	33	NMOD	_	_
33	market	_	NN	_	_	31	OBJ	_	_
34	for	_	IN	_	_	33	NMOD	_	_
35	blood-clot	_	NN	_	_	36	NMOD	_	_
36	drugs	_	NNS	_	_	34	PMOD	_	_
37	in	_	IN	_	_	36	NMOD	_	_
38	general	_	NN	_	_	37	PMOD	_	_
39	.	_	.	_	_	4	P	_	_

1	A	_	DT	_	_	3	NMOD	_	_
2	Genentech	_	NNP	_	_	3	NMOD	_	_
3	spokeswoman	_	NN	_	_	4	SBJ	_	_
4	said	_	VBD	_	_	0	ROOT	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	agreement	_	NN	_	_	7	SBJ	_	_
7	calls	_	VBZ	_	_	4	OBJ	_	_
8	for	_	IN	_	_	7	ADV	_	_
9	Hoechst	_	NNP	_	_	10	SBJ	_	_
10	to	_	TO	_	_	8	SUB	_	_
11	promote	_	VB	_	_	10	IM	_	_
12	TPA	_	NNP	_	_	11	OBJ	_	_
13	for	_	IN	_	_	11	DEP	_	_
14	heart	_	NN	_	_	15	NMOD	_	_
15	patients	_	NNS	_	_	13	PMOD	_	_
16	and	_	CC	_	_	11	COORD	_	_
17	streptokinase	_	NNP	_	_	16	GAP-OBJ	_	_
18	for	_	IN	_	_	16	DEP-GAP	_	_
19	other	_	JJ	_	_	21	NMOD	_	_
20	clot-reducing	_	JJ	_	_	21	NMOD	_	_
21	purposes	_	NNS	_	_	18	PMOD	_	_
22	.	_	.	_	_	4	P	_	_

